Contact us   |  

Departments

Information

Department

About the department

Department name (English): Department of Oncology and Hematology

Department name (original): Dipartimento Malattie Oncologiche ed Ematologiche

Subnetworks of expertise:

  • Myeloid malignancies
  • Lymphoid malignancies
  • Bone marrow failure

Healthcare provider: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Diseases covered by the department:

  • Tumor of hematopoietic and lymphoid tissues
  • Mastocytosis
  • Systemic mastocytosis
  • Indolent systemic mastocytosis
  • Smouldering systemic mastocytosis
  • Isolated bone marrow mastocytosis
  • Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease
  • Aggressive systemic mastocytosis
  • Lymphoadenopathic mastocytosis with eosinophilia
  • Mast cell leukemia
  • Classic mast cell leukemia
  • Aleukemic mast cell leukemia
  • Cutaneous mastocytosis
  • Cutaneous mastocytoma
  • Diffuse cutaneous mastocytosis
  • Mast cell sarcoma
  • Myeloid hemopathy
  • Acute myeloid leukemia
  • Acute myeloid leukemia with multilineage dysplasia
  • Therapy related acute myeloid leukemia and myelodysplastic syndrome
  • Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent
  • Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor
  • Acute myeloid leukemia and myelodysplastic syndromes related to radiation
  • Acute leukemia of ambiguous lineage
  • Acute undifferentiated leukemia
  • Bilineal acute leukemia
  • Acute biphenotypic leukemia
  • Acute myeloid leukemia with recurrent genetic anomaly
  • Acute promyelocytic leukemia
  • Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)
  • Acute myeloid leukemia with 11q23 abnormalities
  • Acute myeloid leukemia with t(8;21)(q22;q22) translocation
  • Acute myeloid leukemia with CEBPA somatic mutations
  • Acute myeloid leukemia with t(8;16)(p11;p13) translocation
  • Acute myeloid leukemia with t(6;9)(p23;q34)
  • Acute myeloid leukemia with t(9;11)(p22;q23)
  • Acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)
  • Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)
  • Acute myeloid leukemia with NPM1 somatic mutations
  • Unclassified acute myeloid leukemia
  • Acute erythroid leukemia
  • Acute megakaryoblastic leukemia
  • Acute panmyelosis with myelofibrosis
  • Acute basophilic leukemia
  • Myeloid sarcoma
  • Acute myeloid leukemia with minimal differentiation
  • Acute myeloblastic leukemia without maturation
  • Acute myeloblastic leukemia with maturation
  • Acute myelomonocytic leukemia
  • Acute monoblastic leukemia
  • Myelodysplastic syndrome
  • Acquired idiopathic sideroblastic anemia
  • Refractory cytopenia with multilineage dysplasia
  • Refractory anemia
  • Unclassified myelodysplastic syndrome
  • Aregenerative anemia
  • Refractory anemia with excess blasts
  • Refractory anemia with excess blasts type 1
  • Refractory anemia with excess blasts type 2
  • Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality
  • Refractory anemia with excess blasts in transformation
  • Myeloproliferative neoplasm
  • Essential thrombocythemia
  • Chronic myeloid leukemia
  • Primary myelofibrosis
  • Polycythemia vera
  • Chronic neutrophilic leukemia
  • Chronic myeloproliferative disease, unclassifiable
  • Chronic eosinophilic leukemia
  • Hypereosinophilic syndrome
  • Idiopathic hypereosinophilic syndrome
  • Primary hypereosinophilic syndrome
  • Secondary hypereosinophilic syndrome
  • Lymphocytic hypereosinophilic syndrome
  • Myelodysplastic/myeloproliferative disease
  • Chronic myelomonocytic leukemia
  • Atypical chronic myeloid leukemia
  • Unclassified myelodysplastic/myeloproliferative disease
  • Myeloid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB or FGFR1
  • Myeloid neoplasm associated with PDGFRA rearrangement
  • Myeloid neoplasm associated with PDGFRB rearrangement
  • Myeloid neoplasm associated with FGFR1 rearrangement
  • Lymphoid hemopathy
  • Autoimmune lymphoproliferative syndrome
  • Plasma cell tumor
  • POEMS syndrome
  • Multiple myeloma
  • AL amyloidosis
  • Primary systemic amyloidosis
  • Primary localized amyloidosis
  • Plasmacytoma
  • Primary plasmacytoma of the bone
  • Extramedullary soft tissue plasmacytoma
  • Non-amyloid monoclonal immunoglobulin deposition disease
  • Heavy chain deposition disease
  • Light and heavy chain deposition disease
  • Light chain deposition disease
  • Heavy chain disease
  • Mu-heavy chain disease
  • Alpha-heavy chain disease
  • Gamma-heavy chain disease
  • Plasma cell leukemia
  • Immunodeficiency-associated lymphoproliferative disease
  • Post-transplant lymphoproliferative disease
  • Lymphoproliferative disease associated with primary immune disease
  • Lymphoma
  • Non-Hodgkin lymphoma
  • Acute lymphoblastic leukemia
  • Precursor B-cell acute lymphoblastic leukemia
  • Precursor T-cell acute lymphoblastic leukemia
  • Mature B-cell acute lymphoblastic leukemia
  • B-cell non-Hodgkin lymphoma
  • Indolent B-cell non-Hodgkin lymphoma
  • Follicular lymphoma
  • Waldenström macroglobulinemia
  • Hairy cell leukemia
  • B-cell chronic lymphocytic leukemia
  • Indolent primary cutaneous B-cell lymphoma
  • Primary cutaneous marginal zone B-cell lymphoma
  • Primary cutaneous follicle center lymphoma
  • Hairy cell leukemia variant
  • Marginal zone lymphoma
  • MALT lymphoma
  • Splenic marginal zone lymphoma
  • Nodal marginal zone B-cell lymphoma
  • Splenic diffuse red pulp small B-cell lymphoma
  • Lymphoplasmacytic lymphoma without IgM production
  • Aggressive B-cell non-Hodgkin lymphoma
  • Burkitt lymphoma
  • Diffuse large B-cell lymphoma
  • Lymphomatoid granulomatosis
  • Primary mediastinal large B-cell lymphoma
  • Intravascular large B-cell lymphoma
  • Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly
  • Diffuse large B-cell lymphoma of the central nervous system
  • T-cell/histiocyte rich large B cell lymphoma
  • Diffuse large B-cell lymphoma with chronic inflammation
  • ALK-positive large B-cell lymphoma
  • Primary effusion lymphoma
  • Mantle cell lymphoma
  • B-cell prolymphocytic leukemia
  • Aggressive primary cutaneous B-cell lymphoma
  • Primary cutaneous diffuse large B-cell lymphoma, leg type
  • Plasmablastic lymphoma
  • T-cell non-Hodgkin lymphoma
  • CD4+/CD56+ hematodermic neoplasm
  • T-cell prolymphocytic leukemia
  • T-cell large granular lymphocyte leukemia
  • Aggressive NK-cell leukemia
  • Adult T-cell leukemia/lymphoma
  • Extranodal nasal NK/T cell lymphoma
  • Enteropathy-associated T-cell lymphoma
  • Hepatosplenic T-cell lymphoma
  • Angioimmunoblastic T-cell lymphoma
  • Anaplastic large cell lymphoma
  • ALK-positive anaplastic large cell lymphoma
  • ALK-negative anaplastic large cell lymphoma
  • Primary cutaneous T-cell lymphoma
  • Indolent primary cutaneous T-cell lymphoma
  • Primary cutaneous CD30+ T-cell lymphoproliferative disease
  • Lymphomatoid papulosis
  • Primary cutaneous anaplastic large cell lymphoma
  • Subcutaneous panniculitis-like T-cell lymphoma
  • Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma
  • Mycosis fungoides and variants
  • Classic mycosis fungoides
  • Folliculotropic mycosis fungoides
  • Aggressive primary cutaneous T-cell lymphoma
  • Sézary syndrome
  • Primary cutaneous peripheral T-cell lymphoma not otherwise specified
  • Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma
  • Primary cutaneous gamma/delta-positive T-cell lymphoma
  • Peripheral T-cell lymphoma NOS
  • Hodgkin lymphoma
  • Classic Hodgkin lymphoma
  • Classic Hodgkin lymphoma, nodular sclerosis type
  • Classic Hodgkin lymphoma, mixed cellularity type
  • Classic Hodgkin lymphoma, lymphocyte-rich type
  • Classic Hodgkin lymphoma, lymphocyte-depleted type
  • Nodular lymphocyte predominant Hodgkin lymphoma
  • Composite lymphoma
  • Primary organ-specific lymphoma
  • Primary pulmonary lymphoma
  • Primary cutaneous lymphoma
  • Primary cutaneous B-cell lymphoma
  • Primary central nervous system lymphoma
  • Thyroid lymphoma
  • Primary oculocerebral lymphoma
  • Primary intraocular lymphoma
  • Primary bone lymphoma
  • Primary lymphoma of the conjunctiva
  • Persistent polyclonal B-cell lymphocytosis
  • Castleman disease
  • Localized Castleman disease
  • Multicentric Castleman disease
  • Polycythemia
  • Secondary polycythemia
  • Rare anemia
  • Rare hemolytic anemia
  • Rare acquired hemolytic anemia
  • Paroxysmal nocturnal hemoglobinuria
  • Aplastic anemia
  • Rare constitutional aplastic anemia
  • Fanconi anemia
  • Rare acquired aplastic anemia
  • Idiopathic aplastic anemia
  • Red cell aplasia
  • Adult pure red cell aplasia
  • Rare deficiency anemia

Service offered

  • Diagnostics
  • Treatment and care

Patients covered

  • Adults
  • Ageing

Department phone number: +39 051 2141396

Health professionals

Name Surname Academic title Charge